Momenta Pharmaceuticals is a biotechnology company that specializes in the detailed structural analysis and design of complex sugars for the development of improved versions of existing drugs, the development of novel drugs and the discovery of new biological processes. The company also utilizes its ability to sequence the molecular structure of sugars to create technology-enabled generic versions of complex sugar-based products. Its advanced product candidate, M-Enoxaparin, is designed to be a technology-enabled generic version of Lovenox, an often-prescribed low molecular weight heparin. The company s technology provides a better understanding of the roles that sugars play in cellular function, disease and drug action. Momenta Pharmaceuticals is headquartered in Cambridge, Mass.
Partial Data by Infogroup (c) 2024. All rights reserved.
Partial Data by Foursquare.